386 related articles for article (PubMed ID: 30153180)
1. The Use of Left Ventricular Assist Devices in End-Stage Heart Failure.
Blair A
Crit Care Nurs Q; 2018; 41(4):376-382. PubMed ID: 30153180
[TBL] [Abstract][Full Text] [Related]
2. New role of mechanical assist device as bridge to transplant: USA perspective.
Mohamed A; Mehta N; Eisen HJ
Curr Opin Organ Transplant; 2017 Jun; 22(3):231-235. PubMed ID: 28441157
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
[TBL] [Abstract][Full Text] [Related]
4. Ethical challenges with deactivation of durable mechanical circulatory support at the end of life: left ventricular assist devices and total artificial hearts.
Rady MY; Verheijde JL
J Intensive Care Med; 2014; 29(1):3-12. PubMed ID: 22398630
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.
Lima B; Kale P; Gonzalez-Stawinski GV; Kuiper JJ; Carey S; Hall SA
Am J Cardiol; 2016 May; 117(10):1622-1628. PubMed ID: 27061705
[TBL] [Abstract][Full Text] [Related]
6. Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs.
Sunagawa G; Koprivanac M; Karimov JH; Moazami N; Fukamachi K
Expert Rev Cardiovasc Ther; 2017 May; 15(5):377-387. PubMed ID: 28351172
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients implanted with a left ventricular assist device at nontransplant mechanical circulatory support centers.
Katz MR; Dickinson MG; Raval NY; Slater JP; Dean DA; Zeevi GR; Horn EM; Salemi A
Am J Cardiol; 2015 May; 115(9):1254-9. PubMed ID: 25772738
[TBL] [Abstract][Full Text] [Related]
8. Cardiac recovery during mechanical assist device support.
Maybaum S; Kamalakannan G; Murthy S
Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
[TBL] [Abstract][Full Text] [Related]
9. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
Chew DS; Manns B; Miller RJH; Sharma N; Exner DV
Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608
[TBL] [Abstract][Full Text] [Related]
10. Durable mechanical circulatory support as bridge to heart transplantation.
Badiwala M; Dvirnik N; Rao V
Curr Opin Organ Transplant; 2022 Oct; 27(5):488-494. PubMed ID: 35950884
[TBL] [Abstract][Full Text] [Related]
11. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.
Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y
Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890
[TBL] [Abstract][Full Text] [Related]
12. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
13. Patient selection for left ventricular assist devices.
Lund LH; Matthews J; Aaronson K
Eur J Heart Fail; 2010 May; 12(5):434-43. PubMed ID: 20172939
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist devices.
Birks EJ
Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
[TBL] [Abstract][Full Text] [Related]
15. Continuous flow left ventricular assist devices: a valid option for heart failure patients.
Carrel T; Englberger L; Martinelli MV; Takala J; Boesch C; Sigurdadottir V; Gygax E; Kadner A; Mohacsi P
Swiss Med Wkly; 2012; 142():w13701. PubMed ID: 23135811
[TBL] [Abstract][Full Text] [Related]
16. A contemporary review of mechanical circulatory support.
Patel CB; Cowger JA; Zuckermann A
J Heart Lung Transplant; 2014 Jul; 33(7):667-74. PubMed ID: 24721183
[TBL] [Abstract][Full Text] [Related]
17. Destination therapy with left ventricular assist devices: patient selection and outcomes.
Slaughter MS; Meyer AL; Birks EJ
Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
[TBL] [Abstract][Full Text] [Related]
18. Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.
Brugts JJ; Caliskan K
Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):145-53. PubMed ID: 24417434
[TBL] [Abstract][Full Text] [Related]
19. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
20. An update on mechanical circulatory support for heart failure therapy.
Toeg HD; Al-Atassi T; Garcia JP; Ruel M
Curr Opin Cardiol; 2014 Mar; 29(2):167-73. PubMed ID: 24395064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
